S0820, Adenoma and Second Primary Prevention Trial

NCT01349881 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

354

Enrollment

NETWORK

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Eflornithine placebo & sulindac placebo
DRUG: eflornithine & sulindac placebo
DRUG: Eflornithine placebo & sulindac
DRUG: Eflornithine plus sulindac

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]